Ömer Erküner
机构: MD PhD, Maastricht University Medical Center
每年引用次数
引用次数
引用: 435
H-指数: 10
I10-指数 : 13
出版物: 27
P1380Gender differences in the progression of atrial fibrillation in low-risk paroxysmal AF patients with hypertension: the role of left ventricular hypertrophy
O. Erkuner , R. Nieuwlaat , AJ. Camm , A. Capucci
Europace 19 269 -270
2017
Anticoagulation management in patients with atrial fibrillation undergoing elective electrical cardioversion
O Erkuner , R Claessens , R Pisters , EAMP Dudink
EUROPEAN HEART JOURNAL 37 494 -494
2016
External electrical cardioversion in patients with cardiac implantable electronic devices: Is it safe and is immediate device interrogation necessary?
Nikki AHA Pluymaekers , Elton AMP Dudink , Lucas Boersma , Ömer Erküner
Pacing and Clinical Electrophysiology 41 ( 10) 1336 -1340
2
2018
Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE V.
Ruben R De With , Ömer Erküner , Michiel Rienstra , Bao-Oanh Nguyen
Europace 22 ( 8) 1162 -1172
5
2020
Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events.
Ömer Erküner , Roy Claessen , Ron Pisters , Germaine Schulmer
International Journal of Cardiology 225 337 -341
2016
Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey)
Ömer Erküner , Elton A.M.P. Dudink , Robby Nieuwlaat , Michiel Rienstra
American Journal of Cardiology 122 ( 4) 578 -583
6
2018
Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies
Ruben R De With , Vicente Artola Arita , Bao-Oanh Nguyen , Dominik Linz
EP Europace 24 ( 2) 193 -201
9
2022
Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation: data from the RACE V study
Vicente Artola Arita , Martijn E Van De Lande , Neda Khalilian Ekrami , Bao-Oanh Nguyen
Europace 25 ( 4) 1323 -1331
4
2023
The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey
Elton AMP Dudink , Ömer Erküner , Jenny Berg , Robby Nieuwlaat
EP Europace 20 ( 6) 929 -934
52
2018
Occurrence of Premature Battery Depletion in a Large Multicenter Registry of Subcutaneous Cardioverter-Defibrillator Patients
Jonas Wörmann , Marc Strik , Stjepan Jurisic , Kara Stout
Europace euae170 -euae170
2024
Incidence, Implications, and Management of Sense-B-Noise Failure in Subcutaneous Cardioverter-Defibrillator Patients: insights from a large Multicenter Registry
Jonas Wörmann , Marc Strik , Stjepan Jurisic , Kara Stout
Europace euae161 -euae161
2024
External electrical cardioversion in patients with cardiac implantable electronic devices: is it safe
Nikki AHA Pluymaekers , Elton AMP Dudink , Lucas Boersma , Ömer Erküner
Spontaneous dissection of a left internal mammary artery bypass graft: images in cardiology
Ömer Erküner , Wehab Ahmed , Filip Eerens
European Heart Journal-Case Reports 5 ( 6) ytab232 -ytab232
2021
Improving the understanding of atrial fibrillation progression and the appropriate use of anticoagulants
Ömer Erküner
2021
Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry.
E Mirrakhimov , K A Kulzida , A Erglis , L Poposka
Europace 23 ( 2) 174 -183
56
2021
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general long‐term registry
Vincenzo L Malavasi , Marco Vitolo , Marco Proietti , Igor Diemberger
European journal of clinical investigation 52 ( 7) e13773 -e13773
9
2022
Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry
Wern Yew Ding , Tatjana S Potpara , Carina Blomström‐Lundqvist , Giuseppe Boriani
European journal of clinical investigation 52 ( 6) e13745 -e13745
9
2022
Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry
Wern Yew Ding , Agnieszka Kotalczyk , Giuseppe Boriani , Francisco Marin
European journal of internal medicine 103 41 -49
6
2022
Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry
Marco Vitolo , Vincenzo L Malavasi , Marco Proietti , Igor Diemberger
European journal of internal medicine 99 45 -56
4
2022
Stroke risk in patients with device-detected atrial high-rate episodes
Ö Erküner , M Rienstra , IC Van Gelder , U Schotten
Netherlands Heart Journal 26 177 -181
10
2018